Kannaway, a subsidiary of Medical Marijuana, Inc., announced that Kannaway Japan had its best revenue month in company history in November 2021. This new revenue benchmark breaks a previous record set in September of 2021 for highest revenue within the division.
“We’ve experienced tremendous growth and success in Japan this quarter,” said Kannaway CEO Blake Schroeder. “We are excited about our continued development throughout Asia-Pacific as we continue to expand our presence throughout the region.”
The company expects the CBD oil market within the Asia-Pacific region to reach $5.3 billion by 2025, and sees it as one of the fastest-growing regions within the cannabidiol market.
“The popularity of CBD products in Japan is growing rapidly and we have been able to help further this trend by connecting with consumers to help them become educated on what CBD is and what high-quality CBD products are best for them,” said Kannaway® Global Sales Officer Peter Dale. “We are proud to be the market leaders in the CBD category in Japan and around the world.”